Overview

Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.

Status:
Unknown status
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Primary objective of this pilot study is to evaluate the effect of recombinant human lactoferrin on the rate of infection with Clostridium difficile in long-term care patients supported by enteral feeding requiring broad spectrum antibiotics.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Ventria Bioscience
Treatments:
Lactoferrin